Cargando…
Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
To systematically assess the effect of metformin on colorectal cancer (CRC) risk and mortality in type 2 diabetes mellitus (T2DM) patients. We conducted a systematic search of PubMed, Web of Science, and the Cochrane Library databases for relevant articles before August 2015. Two investigators ident...
Autores principales: | He, Xing-kang, Su, Ting-ting, Si, Jian-min, Sun, Lei-min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998616/ https://www.ncbi.nlm.nih.gov/pubmed/26886616 http://dx.doi.org/10.1097/MD.0000000000002749 |
Ejemplares similares
-
A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase
por: Li, Ling, et al.
Publicado: (2021) -
Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
por: Shi, Yu-Qi, et al.
Publicado: (2020) -
Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023) -
Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2014) -
Risk factor for diabetes mellitus in pediatric chronic pancreatitis patients
por: Xie, Ting, et al.
Publicado: (2019)